AI Generated Image
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
Action News 5 • • business
Key Points:
- Nearly 360,000 bottles of the antidepressant duloxetine, a generic version of Cymbalta, are being recalled due to high levels of nitrosamines, a chemical that may increase cancer risk.
- The recall, initiated by Breckenridge Pharmaceutical and announced by the FDA on June 4, affects delayed-release capsules in both 30-mg and 60-mg doses with specific lot codes and expiration dates through May 2027.
- The recalled duloxetine capsules were distributed nationwide, and patients are advised to consult their doctor or pharmacist before discontinuing use.
- The 30-mg capsules with lot code 241180C (expiring April 2027) and multiple 60-mg capsule lots with expiration dates from November 2026 to May 2027 are included in the recall.
